World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
106
Citations
43168
World Ranking
6518
National Ranking
3461

David J. Grignon publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where David J. Grignon sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 448 publications — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

David J. Grignon D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where David J. Grignon sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 106 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

David J. Grignon was affiliated with Indiana University in the United States. Their research spanned fields such as Medicine and Biochemistry, Genetics and Molecular Biology, with a focus on subfields including Pulmonary and Respiratory Medicine, Surgery, Molecular Biology, Rheumatology, and Cancer Research.

Their work covered several topics related to cancer and urologic health. Key topics included:

  • Renal cell carcinoma treatment
  • Renal and related cancers
  • Bladder and Urothelial Cancer Treatments
  • Prostate Cancer Treatment and Research
  • Urologic and reproductive health conditions
  • Urinary and Genital Oncology Studies
  • Prostate Cancer Diagnosis and Treatment

Grignon's publication record included papers in prominent venues such as The American Journal of Surgical Pathology, Modern Pathology, The Lancet Oncology, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin, and Archives of Pathology & Laboratory Medicine. Frequent publication venues with the number of publications were:

  • The American Journal of Surgical Pathology (8)
  • Modern Pathology (2)
  • The Lancet Oncology (1)
  • Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin (1)
  • Archives of Pathology & Laboratory Medicine (1)

Some of their recent papers included:

  • The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma, 2020, The American Journal of Surgical Pathology
  • Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study, 2020, The Lancet Oncology
  • Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers, 2020, The American Journal of Surgical Pathology
  • Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers. I. Molecular Biomarkers in Prostate Cancer, 2020, The American Journal of Surgical Pathology
  • Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers, 2020, The American Journal of Surgical Pathology

David J. Grignon coauthored frequently with several researchers, including Theodorus van der Kwast, Glen Kristiansen, Sean R. Williamson, Lars Egevad, and Liang Cheng.

The scientist also contributed to academic book publications, including a work titled Tumors of the Kidney, Bladder, and Related Urinary Structures, published in 2021 under the American Registry of PathologyArlington, Virginia eBooks, which received citations.

Best Publications

  • Consensus statement: Guidelines for PSA following radiation therapy

    James D. Cox;David J. Grignon;Richard S. Kaplan;James T. Parsons

  • The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder

    Jonathan I. Epstein;Mahul B. Amin;Victor R. Reuter;Fathollah K. Mostofi

  • Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma--long-term results of phase III RTOG 85-31.

    Miljenko V. Pilepich;Kathryn Winter;Colleen A. Lawton;Robert E. Krisch

  • The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia

    John R. Srigley;Brett Delahunt;John N. Eble;Lars Egevad

  • Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate

    Miljenko V. Pilepich;Kathryn Winter;Madhu J. John;John B. Mesic

  • Phase III Trial of Long-Term Adjuvant Androgen Deprivation After Neoadjuvant Hormonal Cytoreduction and Radiotherapy in Locally Advanced Carcinoma of the Prostate: The Radiation Therapy Oncology Group Protocol 92–02

    Gerald E. Hanks;Thomas F. Pajak;Arthur Porter;David Grignon

  • Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31.

    M V Pilepich;R Caplan;R W Byhardt;C A Lawton

  • Short-Term Neoadjuvant Androgen Deprivation Therapy and External-Beam Radiotherapy for Locally Advanced Prostate Cancer: Long-Term Results of RTOG 8610

    Mack Roach;Kyounghwa Bae;Joycelyn Speight;Harvey B. Wolkov

  • High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20-69: an autopsy study of 249 cases.

    W. A. Sakr;D. J. Grignon;J. D. Crissman;L. K. Heilbrun

  • The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters

    Brett Delahunt;John C. Cheville;Guido Martignoni;Peter A. Humphrey

  • Ten-Year Follow-Up of Radiation Therapy Oncology Group Protocol 92-02: A Phase III Trial of the Duration of Elective Androgen Deprivation in Locally Advanced Prostate Cancer

    Eric M. Horwitz;Kyounghwa Bae;Gerald E. Hanks;Arthur Porter

  • Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the radiation therapy oncology group

    Miljenko V. Pilepich;William T. Sause;William U. Shipley;John M. Krall

  • Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer

    William U. Shipley;Wendy Seiferheld;Himanshu R. Lukka;Pierre P. Major

  • Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy

    Omer Kucuk;Fazlul H. Sarkar;Wael Sakr;Zora Djuric

  • Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients

    David J. Grignon;Jae Y. Ro;Alberto G. Ayala;David T. Shum

  • Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study.

    Peter Ström;Kimmo Kartasalo;Henrik Olsson;Leslie Solorzano

  • Prognostic Factors in Prostate Cancer

    David G. Bostwick;David J. Grignon;M. Elizabeth H. Hammond;Mahul B. Amin

  • Primary adenocarcinoma of the urinary bladder: A clinicopathologic analysis of 72 cases

    David J. Grignon;Jae Y. Ro;Alberto G. Ayala;Douglas E. Johnson

  • The prostatic capsule: does it exist? Its importance in the staging and treatment of prostatic carcinoma.

    Alberto G. Ayala;Jae Y. Ro;Richard Babaian;Patricia Troncoso

  • Mixed epithelial and stromal tumor of the kidney.

    N. Adsay;John Eble;John Srigley;Edward Jones

Frequent Co-Authors

Wael Sakr
Wael Sakr Wayne State University
Jae Y. Ro
Jae Y. Ro Cornell University
Alberto G. Ayala
Alberto G. Ayala Cornell University
David P. Wood
David P. Wood University of Michigan–Ann Arbor
Liang Cheng
Liang Cheng Brown University
John N. Eble
John N. Eble Indiana University
Howard M. Sandler
Howard M. Sandler Cedars-Sinai Medical Center
Fazlul H. Sarkar
Fazlul H. Sarkar Wayne State University
John R. Srigley
John R. Srigley University of Toronto
Kenneth V. Honn
Kenneth V. Honn Wayne State University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring related online degrees can broaden your career options within the wide field of healthcare and medicine. For students seeking quicker entry into patient care, attending a nursing school without TEAS test requirements can make the admission process smoother, letting you focus on your coursework without extra exam stress.

For those interested in leadership roles, an accelerated healthcare administration degree online offers a fast track to positions in hospital management, policy development, and healthcare operations. Registered nurses looking to upskill might benefit from ADN to MSN bridge programs, which allow them to rapidly obtain advanced credentials while balancing work and study.

Additionally, a growing interest in preventive care and wellness opens new avenues in nutrition. Earning an online bachelor's degree in nutrition equips students for roles in counseling, research, or public health initiatives. Each of these pathways provides flexibility and opportunity for those passionate about impacting health outcomes, even beyond traditional medical practice.

Best Scientists Citing David J. Grignon

Recently Published Articles